
Real-Time Follicle Counting AI Ultrasound Probe Market Report 2026
Global Outlook – By Component (Hardware, Software, Services), By Technology (Two Dimensional Ultrasound, Three Dimensional Or Four Dimensional Ultrasound, Other Technologies), By Application (Follicle Monitoring For In Vitro Fertilization, Polycystic Ovary Syndrome Assessment, Ovarian Reserve Testing, Fertility Preservation Evaluation, Gynecological Research), By End User (Fertility Clinics, Hospitals, Diagnostic Imaging Centers, Research Institutes) – Market Size, Trends, Strategies, and Forecast to 2030
Real-Time Follicle Counting AI Ultrasound Probe Market Overview
• Real-Time Follicle Counting AI Ultrasound Probe market size has reached to $0.49 billion in 2025 • Expected to grow to $0.91 billion in 2030 at a compound annual growth rate (CAGR) of 13.3% • Growth Driver: Surge In Infertility Cases Globally Fueling The Growth Of The Market Due To Growing Patient Demand For Precision Ovarian Monitoring • Market Trend: Next-Generation AI Ultrasound Supports Automated Follicle Counting • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Real-Time Follicle Counting AI Ultrasound Probe Market?
Real-time follicle counting AI ultrasound probe is a technology-enabled medical imaging solution that allows clinicians to assess and count ovarian follicles in real time using an ai-integrated ultrasound probe. Its primary goal is to enhance accuracy and efficiency in fertility diagnostics, reducing manual intervention and variability in follicle assessment. It also improves clinical decision-making, shortens examination time, enhances patient outcomes, and supports the digital transformation of reproductive healthcare services. The main components of real-time follicle counting AI ultrasound probes include hardware, software, and services. Hardware refers to ultrasound probes equipped with imaging sensors and integrated artificial intelligence capabilities that enable automated real-time detection, measurement, and counting of ovarian follicles during fertility assessments. These systems utilize technologies such as two dimensional ultrasound, three dimensional or four dimensional ultrasound, and other technologies. The various applications involved are follicle monitoring for in vitro fertilization, polycystic ovary syndrome assessment, ovarian reserve testing, fertility preservation evaluation, and gynecological research and they are utilized by end users including fertility clinics, hospitals, diagnostic imaging centers, and research institutes.
What Is The Real-Time Follicle Counting AI Ultrasound Probe Market Size and Share 2026?
The real-time follicle counting ai ultrasound probe market size has grown rapidly in recent years. It will grow from $0.49 billion in 2025 to $0.55 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increasing demand for fertility diagnostics, rising adoption of assisted reproductive technologies, growing prevalence of infertility disorders, expanding fertility clinic infrastructure, increasing need for accurate follicle monitoring.What Is The Real-Time Follicle Counting AI Ultrasound Probe Market Growth Forecast?
The real-time follicle counting ai ultrasound probe market size is expected to see rapid growth in the next few years. It will grow to $0.91 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to growing adoption of AI powered ultrasound analysis, increasing demand for real time fertility monitoring solutions, rising focus on reducing diagnostic variability, expanding digital transformation in reproductive healthcare, higher investment in advanced medical imaging technologies. Major trends in the forecast period include growing adoption of ai based fertility imaging solutions, increasing demand for automated follicle assessment systems, rising integration of real time ultrasound diagnostics, expansion of digital reproductive healthcare workflows, higher focus on improving fertility treatment accuracy.
Global Real-Time Follicle Counting AI Ultrasound Probe Market Segmentation
1) By Component: Hardware, Software, Services 2) By Technology: Two Dimensional Ultrasound, Three Dimensional Or Four Dimensional Ultrasound, Other Technologies 3) By Application: Follicle Monitoring For In Vitro Fertilization, Polycystic Ovary Syndrome Assessment, Ovarian Reserve Testing, Fertility Preservation Evaluation, Gynecological Research 4) By End User: Fertility Clinics, Hospitals, Diagnostic Imaging Centers, Research Institutes Subsegments: 1) By Hardware: Ultrasound Imaging Probes, Portable Ultrasound Devices, High Resolution Transducers, Handheld Imaging Devices 2) By Software: Image Processing Software, Artificial Intelligence Analysis Software, Diagnostic Support Software, Data Management Platforms 3) By Services: Installation And Integration Services, Maintenance And Support Services, Training And Education Services, Consulting ServicesWhat Is The Driver Of The Real-Time Follicle Counting AI Ultrasound Probe Market?
The rise in infertility cases globally is expected to propel the growth of the real-time follicle counting AI ultrasound probe market going forward. Infertility is a disease of the male or female reproductive system, defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. Globally, infertility cases continue to rise as women increasingly delay childbearing due to career prioritization and evolving social norms, reducing natural conception rates among those of reproductive age. This expanding patient population intensifies demand for precise, technology-driven fertility diagnostics, and real-time follicle counting AI ultrasound probes directly address this need by enabling clinicians to assess ovarian follicle development with greater speed and accuracy, thereby supporting more effective assisted reproductive technology (ART) treatment decisions. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people globally, face infertility, highlighting the pressing need to improve access to affordable, high-quality fertility care for those affected. Therefore, the rise in infertility cases globally is driving the growth of the real-time follicle counting AI ultrasound probe industry.Key Players In The Global Real-Time Follicle Counting AI Ultrasound Probe Market
Major companies operating in the real-time follicle counting ai ultrasound probe market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, Fujifilm Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Canon Medical Systems Corporation, Samsung Medison, Esaote S.p.A., Shenzhen SonoScape Medical Corp., Edan Instruments Inc., CHISON Medical Technologies Co. Ltd., Alpinion Medical Systems Co. Ltd., Butterfly Network Inc., Terason, Clarius Mobile Health Corp., Exo Imaging Inc., Pulsenmore Ltd., Cycle Clarity Inc., Alife Health Inc., VinBrain (VinDr AI)
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Global Real-Time Follicle Counting AI Ultrasound Probe Market Trends and Insights
Major companies operating in the real-time follicle counting AI ultrasound probe market are focusing on integrating AI-powered follicle assessment and automation capabilities into ultrasound systems to improve imaging accuracy, streamline fertility workflows, and reduce operator dependency. AI-powered follicle assessment uses deep learning algorithms to automatically detect, count, measure, and monitor ovarian follicles in real time, supporting faster and more consistent fertility evaluations. For instance, in January 2025, GE HealthCare Technologies Inc., a US-based medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Voluson Expert Series ultrasound systems, including Voluson Expert 22, 20, and 18. The systems incorporate AI-powered automation features, including SonoAVC Follicle 2.0, which enables automated ovarian follicle detection, counting, and measurement to enhance workflow efficiency, imaging performance, and clinical decision-making in fertility assessment and assisted reproductive procedures.What Are Latest Mergers And Acquisitions In The Real-Time Follicle Counting AI Ultrasound Probe Market?
In June 2025, Cycle Clarity, a US-based fertility technology company, partnered with Artisan to integrate Cycle Clarity’s AI-driven follicular monitoring data and insights directly with Artisan’s electronic medical record platform, enabling automated data transmission and more seamless fertility clinic workflows. Through this partnership, the companies aim to eliminate manual data entry, improve access to real-time fertility monitoring information, reduce administrative and nursing workload, and support more efficient and personalized patient care. Artisan is a US-based cloud-based technology company that provides electronic medical record solutions designed specifically for fertility practices, supporting clinical workflows, patient communication, and integration with ultrasound and other fertility-care technologies.
Regional Outlook
North America was the largest region in the real-time follicle counting ai ultrasound probe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Real-Time Follicle Counting AI Ultrasound Probe Market?
The real-time follicle counting AI ultrasound probe market consists of revenues earned by entities by providing services such as AI-assisted follicle detection and counting, automated follicle measurement and tracking, ovarian reserve assessment, fertility treatment monitoring, ultrasound imaging and interpretation, cloud-based image analysis, and clinical workflow integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time follicle counting AI ultrasound probe market also includes sales of AI-enabled ultrasound probes, ultrasound imaging systems, transvaginal ultrasound transducers, portable ultrasound devices, image processing workstations, and fertility imaging accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
What Key Data and Analysis Are Included in the Real-Time Follicle Counting AI Ultrasound Probe Market Report 2026?
The real-time follicle counting ai ultrasound probe market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the real-time follicle counting ai ultrasound probe industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Real-Time Follicle Counting AI Ultrasound Probe Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.55 billion |
| Revenue Forecast In 2030 | $0.91 billion |
| Growth Rate | CAGR of 13.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Component, Technology, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, Fujifilm Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Canon Medical Systems Corporation, Samsung Medison, Esaote S.p.A., Shenzhen SonoScape Medical Corp., Edan Instruments Inc., CHISON Medical Technologies Co. Ltd., Alpinion Medical Systems Co. Ltd., Butterfly Network Inc., Terason, Clarius Mobile Health Corp., Exo Imaging Inc., Pulsenmore Ltd., Cycle Clarity Inc., Alife Health Inc., VinBrain (VinDr AI) |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
